Market Research Blog – Page 1486 – New Product Development

Embedded Finance Market Set for Robust Growth: Projected to Reach $291.3 Billion by 2033 with a 16.5% CAGR

It is projected that the embedded finance industry would grow at a robust 16.5% compound annual growth rate (CAGR) from 2023 to 2033. The market is anticipated to be valued at US$ 63.2 billion in 2023 and to have a market share of US$ 291.3 billion by 2033.

The technical advantages along with the expanding financial services including banking and non-banking options are flourishing the market growth. Furthermore, the rapid automation and adoption of smart platforms of different spaces for high productivity and efficiency are propelling growth.
Financial giants are partnering with technological platforms for innovative solutions. For example, Mastercard and Fabrick have signed a partnership to boost embedded finance. New services like buy now pay later (BNPL) and credit reporting are good examples of embedded finance.
The expanding sales and extended chains of banks and financial companies are expected to adopt these new systems in to improve the services offered. Alongside this, the increased convenience, quick transaction, and highly accessible interface is making embedded finance systems future-ready.
The growing sales of financial services have also increased the importance of data. Thus, the embedded finance systems also deliver a relevant collection of data while adding inclusion and convenience to the end user’s plate.
The other benefits include the generation of additional revenue streams while increasing the product’s stickiness, and enhanced customer experience.

Key Takeaways:

The United States market leads the embedded finance market in terms of market share in North America. The United States region held a market share of 22.3% in 2023. The growth in this region is attributed to expanding financial firms, and the government’s adoption of the latest technologies. North American region held a significant market share of 32.5% in 2022.
Germany’s market is another successful market in the Europe region. The market holds a market share of 12.3% in 2022. The growth is attributed to the presence of new embedded finance platforms such as Plaid, and Alviere Hive. Europe region held a market share of 25.4% in 2022
India embedded finance market booms at a CAGR of 19.5% during the forecast period. The market’s growth is attributed to the new banking policies, enlarged non-banking policies, and high penetration of non-banking platforms.
China’s market also thrives at a CAGR of 17.7% between 2023 and 2033. The growth is caused by the banking reforms and increased focus on consumer inclusivity.
Based on type, the embedded banking segment held a leading market share of 32.1% in 2022.
Based on end-user type, the investment banks and investments company segment perform well as it held a leading market share of 27.2% in 2022.

Competitive Landscape:

The key vendors focus on adding value to the embedded finance systems and easy deployment procedures. Moreover, key competitors also merge, acquire, and partner with other companies to increase their supply chain and distribution channel.

Major Players in this Market:

Bankable
Banxware
Cross River
Resolve
Parafin
TreviPay
Balance
Stripe

Recent Market Developments:

Finix has introduced embedded payments and the vertical SaaS conundrum. The addition of embedded payments is increasing revenue, reducing the payment strike, and easy customer engagement.
Flywire embedded experience is using smart technologies to secure payments without leaving the website.

Key Segments Covered are:

By Type:

Embedded Banking
Embedded Insurance
Embedded Investments
Embedded Lending
Embedded Payment

By End User:

Loans Associations
Investment Banks & Investment Companies
Brokerage Firms
Insurance Companies
Mortgage Companies

By Key Regions:

North America
Latin America
Europe
Japan
Asia Pacific Excluding Japan
The Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Debt Collection Software Market: Valuation to Reach US$ 11.5 Billion by 2033, Driven by Efficiency Gains – FMI

The Debt Collection Software Market is currently estimated at US$ 4.3 billion in 2023 and is poised for substantial growth, projected to reach US$ 11.5 billion by 2033. This remarkable expansion reflects a robust Compound Annual Growth Rate (CAGR) of 10.2% over the forecast period from 2022 to 2032.

Debt collection software aids in the automatic and daily monitoring of customers’ accounts, as well as the provision of loan installation notifications and alerts. This enables financial institutions to provide timely updates and cautions about loan Equated Monthly Instalments (EMI).

Debt collection software also assists financial institutions in complying with consumer protection regulations by recognizing bankruptcy status and litigious customers. As a result, the debt collection software market is fast growing.

Debt collection services are gaining popularity as a result of their ability to assist businesses with strategy formulation, software deployment, and implementation based on their unique needs. As a result, a rise in the use of debt collection software across various industries, such as collection agencies, financial institutions, government, telecom & utilities, real estate, commerce, and healthcare, is supporting the growth in the sales of debt collection software.

As per the recent debt collection software market study, several firms from various industry verticals are rising in demand for multichannel communication solutions to communicate with debtors and advance their collection methods using cutting-edge automated technologies. This reason is increasing the sales of debt collection software, which is propelling the debt collection software market’s growth.

The adoption of debt collection services is expanding among major businesses, as opposed to small and medium-sized businesses, due to economies of scale and pricing. This indicates that the market is expected to attract excellent sales opportunities from significant corporations around the world.

Key Takeaways

Data analytics with debt collection solutions is a trend that is projected to gain pace in North America, particularly in the United States, shortly. Debt collection software providers understand the importance of big data analytics and predictive analytics in debt collection, as well as the advantages of data visibility in terms of compliance.
The software component segment of the debt collection software market is expected to rise at a CAGR of 9.3% throughout the forecast period.
The increasing willingness of businesses to use debt collection software to streamline the debt recovery process is expected to drive demand for debt collection software solutions in the Asia Pacific.
The US debt collection software market size is projected to reach a valuation of US$ 3.3 Bn by 2032.

Competitive Landscape

As per the debt collection software market analysis by FMI, the global debt collection software market appears to be moderately fragmented in character. Furthermore, the presence of a large number of vendors demonstrates that the market for debt collection software is highly competitive.

As a result, to keep ahead of the competition, key market players are implementing various strategies such as mergers, acquisitions, partnerships, and collaborations. Companies are also benefiting from these techniques as they expand regionally.

Many organizations in the debt collection software market are boosting their research and development spending. One of the main goals of these studies is to improve the quality of the services they offer. These initiatives are expected to help the debt collection software market grow in the coming years.

FIS, Nucleus Software Exports Ltd., Scorto, Inc., Temenos Headquarters SA, CGI, Inc., TransUnion LLC, Sentinel Development Solutions, Inc., Debtcol Software Pty Ltd., Intellect Design Arena Ltd., and Chetu Inc. are some of the key companies operating in the global debt collection software market.

Click to Buy Your Exclusive Report Immediately!

Key Segments

By Component:

Software
Services

By Deployment:

Cloud-based
On-premise

By Organization Size:

SMEs
Large Enterprises

By End user:

Healthcare
Financial Institution
Collection Agencies
Government
Telecom & Utilities
Other

By Region:

North America
Europe
APAC
MEA
Latin America

About Future Market Insights (FMI)

Contact Us:

Call Center AI Market Growth Factors, Opportunities, Ongoing Trends and Key Players 2032

The demand for Call Center AI Market solutions is primarily driven by the extensive adoption of AI-based services across various industries including Banking, Financial Services, and Insurance (BFSI), Information Technology & Telecommunications, healthcare, and the retail sector. These sectors have witnessed a significant surge in the utilization of AI technologies, particularly in streamlining customer interactions and enhancing operational efficiency.

Key Takeaways:

The solutions from the call centre AI market are expected to grow at the fastest CAGR of 13.1% in the component sector.
 Cloud is expected to grow at a high rate in the deployment type sector of the call centre AI market, with a CAGR of 13.4%.
The market size for call centre AI in the United States is expected to reach US$ 2.1 Billion by 2032, growing at a CAGR of 13.4% during the research period.
 UK is expected to reach a market size of US$ US$ 282.1 Billion in the call centre AI market by 2032, with a CAGR of 12.7% during the research period.
China’s call centre AI market is expected to be worth US$ 346.4 Mn by 2032, with a CAGR of 13% over the forecast period.
 Japan is expected to have a market size for call centre AI of US$ 321.0 Mn by 2032, with a CAGR of 12.5% during the research period.
By 2032, South Korea is expected to reach a market size of US$ 210.8 Mn in the call centre AI market, with a CAGR of 12.1% during the research period.

However, the market growth might be challenged by the unsupervised self-learning of chatbots. This restraint stems from concerns related to AI models learning inappropriate or biased behavior from unmonitored interactions. As the industry advances, addressing ethical and regulatory concerns will be crucial to maintaining sustained growth.

Regional Trends:

Geographically, the adoption of Call Center AI solutions is spread across various regions. North America and Europe have traditionally been significant markets, owing to their early adoption of advanced technologies. Meanwhile, the Asia-Pacific region is emerging as a lucrative market due to the rapid expansion of the BFSI, IT & Telecom, and healthcare sectors in the region. The market’s growth is further driven by the presence of a vast customer base and increasing investments in technological advancements.

Competition Analysis:

The Call Center AI market is witnessing intense competition, with several key players contributing to the industry’s growth. Companies are focusing on innovation and research to enhance their product offerings and stay ahead in the market. Collaborations, partnerships, and mergers & acquisitions are some of the strategies employed by companies to expand their market presence and capture a larger share.

Key Segments

By Component:

Compute Platforms
Solutions
Services
- Training & Consulting Services
- System Integration & Deployment Services
- Support & Maintenance Services

By Deployment Type:

On-premises
Cloud

By Vertical:

BFSI
Media & Entertainment
Retail & eCommerce
Travel & Hospitality
Telecom
Healthcare
Others (Automotive, Government, Manufacturing, Education, and Energy & Utilities)

By Region:

North America
Europe
APAC
Middle East and Africa (MEA)
Latin America

Empower Your Strategy: Acquire Our Comprehensive Report Today

About Future Market Insights (FMI)

Contact Us:

Global Hepatitis B Diagnostic Tests Market Expected to Grow Steadily, Reaching USD 1,744.26 Million by 2033

The global hepatitis B diagnostic tests market is poised for significant growth, driven by a combination of increasing disease incidence, awareness initiatives, and advancements in diagnostic technologies. According to recent market analysis, the hepatitis B diagnostic tests market was valued at USD 872.5 million in 2022 and is projected to maintain this valuation by the end of 2023. Over the next decade, the market is expected to achieve a compound annual growth rate (CAGR) of 6.5%, potentially reaching USD 1,744.26 million by 2033.

Key Market Drivers:

Rising Hepatitis B Incidence: The global prevalence of hepatitis B continues to rise, particularly in regions with high disease burden, necessitating increased diagnostic testing. This trend is a primary driver behind the expanding market size.
Awareness Initiatives: Public health campaigns and healthcare initiatives focused on hepatitis B screening and diagnosis are enhancing awareness among at-risk populations. These efforts are crucial in improving early detection rates and driving market growth.
Technological Advancements: Ongoing innovations in diagnostic technologies are enhancing the sensitivity, accuracy, and speed of hepatitis B tests. These advancements not only improve diagnostic outcomes but also contribute to the growing acceptance of diagnostic testing globally.

The market dynamics indicate a promising future for hepatitis B diagnostic tests, with significant opportunities for healthcare providers, diagnostic companies, and investors. As the global healthcare community continues to prioritize infectious disease management and public health initiatives, the demand for reliable and efficient diagnostic solutions is expected to rise steadily.

Key Takeaways from the Market Study:

The market for hepatitis B diagnostic tests expanded at a CAGR of 4.5% from 2018 to 2022.
The Hepatitis B Diagnostic Tests market in the United States is expected to surpass 34.7% market share in 2023.
It is predicted that China would take 23.2% of the worldwide market for hepatitis B diagnostic tests in 2023.
By the end of 2023, the market for hepatitis B diagnostic tests in Japan will hold 7.1% of the global market share.
By 2023, it is expected that the market for hepatitis B diagnostic tests in France would increase by 8%.
By 2023, the Hepatitis B Diagnostic Tests market in the United Kingdom is anticipated to have a 7.8% market share.
In 2023, it is anticipated that the market share held by enzyme immunoassay kits will reach 71.90%.
The hospitals segment will expand quickly at a 6.2% CAGR throughout the projection period.

“The hepatitis B diagnostic tests are promoted through public health programs, increasing liver exams, and healthcare marketing, which raises awareness and diagnoses rates,” remarks an FMI analyst.

Get Old Source Presents the Latest Reports…

Competitive Landscape:

Manufacturers frequently explore new geographical areas to increase their market presence. With healthcare organizations and providers all across the world, they create distribution networks and partnerships. Manufacturers can access untapped client bases by diversifying into new markets and areas with a high hepatitis B incidence.

In order to make sure that their goods adhere to local norms and laws, businesses may also apply for regulatory licenses and certifications in other nations.

Prominent players in the Hepatitis B Diagnostic Tests Market are:

Bio-Rad Laboratories, Inc.
DiaSorin S.p.A.
Abbott Laboratories
Meridian Bioscience
bioMérieux SA Inc.
Vista Diagnostics International
Biogate Laboratories Ltd.
Mitra & Co. Ltd.
Siemens Medical Solutions USA, Inc.
General Biologicals Corporation

Product Portfolio:

A healthcare corporation with a wide range of services, Abbott Laboratories has been involved in the creation of medicines, notably antiviral drugs. They have created medications in the past that are used to treat chronic hepatitis B. One such instance is the drug “Hepsera” (generic name: adefovir dipivoxil), that was used in some individuals to prevent the reproduction of the hepatitis B virus.
“Viread,” which is made by Gilead Sciences, Inc., is one of the treatments for hepatitis B that is often used. Tenofovir disoproxil fumarate (TDF), the active component of Viread, is an antiviral drug intended to prevent the hepatitis B virus (HBV) from replicating in people with chronic hepatitis B infection.

Segmentation Analysis of the Hepatitis B Diagnostic Tests Market:

By Product Type:

Enzyme Immunoassay Kits
- Hepatitis B Surface Antigen Test
- Anti-Hepatitis B Surface Antibody Test
- Anti-Hepatitis B Core Antibody Test
Point-of-Care Testing Kits
- Strips
- Cassettes/Cards

By End User:

Hospitals
Clinics
Diagnostic Centers
Home Care

By Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia and Pacific
East Asia
The Middle East & Africa

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Drug of Abuse Testing Market Projected to Surge to USD 2.69 Billion by 2033, Driven by Increased Demand and Technological Advancements

The drug of abuse testing market is estimated to secure a valuation of USD 1.65 billion in 2023 and is predicted to reach USD 2.69 billion by 2033. The market is estimated to register a CAGR of 5.3% during the forecast period.

A few factors contributing to the global market growth are:

Increase Substance Abuse: The demand for drug abuse testing for prescription and illicit drugs drives the global market. It is significantly used in various settings for drug detection, including schools, workplaces, and rehabilitation centers.
Workplace Safety: Employers across several industries prefer drug testing programs to enhance workplace safety. This testing helps to identify employees under drug influence, which helps to reduce the risk of injuries and accidents.
Sports and Athletics: Drug testing play a key role in maintaining fair competition in sports activities. The government and sports organizations initiate anti-doping, which increases the demand for drug abuse testing to enhance players’ performance.
Advanced Technologies: The rising advanced technologies to develop efficient, accurate, and sensitive drug testing methods fuel the global market. The growing innovations of point-of-care testing, immunoassays, and chromatography techniques drive the global market.
Growing Awareness: The rising awareness of the side effects of drugs and prevention are increasing the adoption of drug abuse testing. Government bodies, healthcare, and NGOs are initiative education campaigns that contribute to expanding the global market.

Key Takeaways:

The drug abuse testing market is estimated to secure a valuation of USD 2.69 billion in 2033 with a CAGR of 5.3% during the forecast period.
In the historical period, the market secured a valuation of USD 1.5 billion in 2022.
The United States dominates the global market by capturing a maximum share of 25.5% during the forecast period.
Germany is significantly driving the global market by registering a share of 4% by 2033.
With a share of 3.3%, Japan is securing a significant share in the global market during the forecast period.

Get Old Source Has the Newest Reports Available…

How are Key Players Adding Value in the Global Market?

Several prominent players consolidates the market presence globally. These players are developing innovative products by adopting advanced technologies. They offer improved and high-quality products to their consumers as per their needs.

Key players are adopting various marketing methodologies to elevate the global market. These marketing methodologies are partnerships, mergers, acquisitions, collaborations, product launches, and agreements. The key players are conveniently provided delivery of their products and services through their distribution networks.

They are marketing and promoting their products in social media, online retailers, and offline platforms to increase their sales volume. These players are significantly expanding the market by providing awareness and educating their customers at trade shows, exhibitions, and seminars.

Recent Developments in the Global Market:

Abbott Laboratories offers a variety of drug abuse testing, such as laboratory testing solutions, immunoassays, and point-of-care testing. The company invests in research and development activities to expand its business portfolio.

Other Essential Players in the Global Market are:

Quest Diagnostics
Roche Holding AG
Thermo Fisher Scientific, Inc.
Siemens AG (Siemens Healthineers)
Abbott Laboratories (Alere, Inc.)
Shimadzu Corporation
Express Diagnostics International Inc.
Drägerwerk AG & Co. KGaA
Laboratory Corporation of America Holdings.

Drug of Abuse Testing Market by Category:

By Drug Type:

Psychostimulants
Narcotic
Cannabinoids
Sedatives
Others

By Technique:

Immunoassay
Chromatography
Rapid Testing

By End User:

Hospitals
Diagnostics Laboratories
Forensic Laboratories
Others

By Region:

North America
Latin America
Europe
Asia Pacific
The Middle East and Africa

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

2-Brides: Discover the Most Extensive Collection of Brides Profiles

2-Brides boasts the biggest catalog of brides profiles that can assist you in meeting your perfect match in no time. Use a variety of search filters to refine the list of profiles, ensuring you encounter those that align with your preferences. This way, you’ll save energy and effort while searching for a partner on 2-Brides.

The historical background of mail order brides dates back for centuries, when solitary settlers posted announcements in the regional newspapers seeking to marry their soulmates from overseas. They hoped that long-distance romance might culminate into strong marriages, offering them an opportunity at better futures.

Today, online dating have revolutionized this industry, offering men a protected method to encounter stunning women from across the world. 2 Brides mail order girlfriend pick a woman by country, age, level of education, lifestyle, interests, and other key criteria. The process is quick, providing fantastic results. The greatest part is that you can conduct it all from the comfort of your home, with nobody being aware unless you choose to share.

foreign women

Why Women Decide to Become Mail Order Brides

Generally, mail order brides are women who enroll on expert dating sites aiming to locate a husband abroad. They complete a registration process, submit images and video clips to validate their identity, and craft a detailed profile page. Then, they await men to make contact with them.

Some women from Russia, for illustration, feel that Western men regard them with greater respect, while others merely want to flee the confining life in their homeland and hunt for different life partners abroad. In any case, it’s indisputable that many of these ladies are appealing and ready to start a family with their perfect match.

Finding the Right Thai Girl

If you’re looking for a gorgeous Thai wife, check out the top dating sites dedicated in connecting single foreign women with men worldwide. These platforms provide a broad selection of unattached Thai women, offering thorough descriptions and nice photos. The greatest aspect of these dating services is their speed, affordability, and effectiveness.

If you decide to experiment with your luck on these dating sites, start by creating a captivating profile highlighting your finest attributes, making you distinguish yourself from the competition. Additionally, reflect on uploading a few high-quality photos, as they’ll draw in more potential partners. Lastly, select a genuine and explanatory username that depicts your actual identity. This’ll ease the process for other users to find your profile and connect with you.

Global Single-Photon Emission Computed Tomography Market Set for Rapid Growth, Valuation to Reach USD 4.76 Billion by 2032

The global single-photon emission computed tomography market is experiencing significant growth, driven by advancements in diagnostic imaging technologies and the increasing prevalence of cardiovascular diseases. According to recent market analysis, the SPECT market reached a valuation of USD 2.28 Billion in 2021 and is projected to rise to USD 2.45 Billion by the end of 2022. Over the forecast period from 2022 to 2032, the market is anticipated to grow at a compound annual growth rate (CAGR) of 6.9%, reaching approximately USD 4.76 Billion by 2032.

Single-photon emission computed tomography is a pivotal nuclear medicine technique that enables 3-D imaging of functional processes within the human body. It utilizes short-lived radioisotopes for non-invasive diagnostic imaging of metabolic processes, playing a crucial role in the detection and management of chronic illnesses.

In 2021, the single imaging gamma cameras segment dominated the global SPECT market with a market share of 75.5%, a trend expected to continue throughout the forecast period. These gamma cameras are integral to SPECT systems, enhancing diagnostic capabilities by providing detailed metabolic and functional data of cells and organs.

The increasing demand for better diagnostic tools, coupled with advancements in organic-specific and dual-modality imaging systems, is driving the expansion of the SPECT market. As healthcare providers prioritize accurate and efficient diagnostic solutions, SPECT technology is poised to play a pivotal role in meeting these demands.

“The global SPECT market is witnessing robust growth driven by technological advancements and the rising burden of cardiovascular diseases,” said FMI. “As we move towards 2032, innovations in imaging systems and enhanced diagnostic capabilities will further accelerate market expansion.”

Key Takeaways: Single-Photon Emission Computed Tomography (SPECT) Market

The global SPECT market reached USD 2.28 billion in 2021 and is expected to reach USD 2.45 billion by 2022.
The market is expected to grow at a CAGR of 6.9% from 2022 to 2032, reaching a valuation of USD 4.76 billion by 2032. This growth is attributed to the rising prevalence of cardiovascular diseases and the demand for better diagnostic tools.
North America, with the USA holding a dominant 38% share in 2021, is expected to continue leading the market due to favorable reimbursement policies for nuclear medicine procedures.
China’s SPECT market, with a 5.3% share in 2021, is projected for healthy growth due to advancements in medical infrastructure, focus on chronic disease management, and government support for cancer research.
Germany, with an aging population and increasing use of radiopharmaceutical diagnostics, is expected to hold a nearly 5% market share due to government funding initiatives.

See the Latest Reports from Get Old Source…

Competitive Landscape:

Major players in the single-photon emission computed tomography (SPECT) market are aggressively pursuing market dominance through strategic partnerships, product launches, and expansion efforts. For example:

In November 2020, GE Healthcare acquired Prismatic Sensors AB, a Swedish startup known for its expertise in photon-counting detectors. This acquisition underscores GE Healthcare’s ongoing commitment to advancing photon-counting CT technology.
In May 2022, Mediso Ltd. acquired Bartec Technologies Ltd., a UK-based company specializing in the supply, installation, and support of Nuclear Medicine and Molecular Imaging equipment and accessories.

These moves highlight the proactive strategies employed by industry leaders to strengthen their positions and drive innovation in the SPECT market.

Key Companies Profiled:

Bruker Corp.
DDD-Diagnostic AS
Digmed Corp.
General Electric Co.
Mediso Ltd.
MiE GmbH
MILabs BV
Siemens Healthineers AG
Spectrum Dynamics Medical Inc.
GE Healthcare
CardiArc
Beijing Hamamatsu Photon Techniques INC.
SHENZHEN BASDA MEDICAL APPARATUS CO., LTD.
PNPMed
NuCare Inc.

Key Market Segments Covered in Single-photon Emission Computed Tomography Industry Research:

By Product:

Single Imaging Gamma Cameras
SPECT/CT

By Application:

Cardiology
Oncology
Neurology
Others

By End User:

Hospitals
Diagnostic Imaging Centers
Ambulatory Surgical Centers

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa(MEA)

About Future Market Insights (FMI)

Contact Us:

Global Veterinary Ultrasound Scanner Market Poised for Rapid Expansion to an estimated USD 284.8 million by 2033

The global veterinary ultrasound scanner market is primed for substantial expansion, projected to reach a valuation of USD 198.1 million by 2023 and showcasing a steady Compound Annual Growth Rate (CAGR) of 3.7% through 2033. According to industry forecasts, this growth trajectory positions the global market to achieve an impressive USD 284.8 million by the end of the forecast period.

Driving this growth are significant technological advancements, such as wireless streaming capabilities featured in models like the IBEX® PRO and LITE, which enhance diagnostic precision and workflow efficiency. Innovations like the OsiriX® viewer for dogs further bolster market dynamics by enabling precise CT prostate volume assessment, minimizing reliance on subjective human observation.

Despite initial challenges, including slower adoption rates in the early stages of the forecast period due to technological lag and pandemic-related factors impacting pet adoption rates, the market has demonstrated resilience. This resilience underscores the increasing importance of veterinary ultrasound scanners in modern veterinary practice, supporting enhanced diagnostic capabilities and patient care.

Key Takeaways from the Market Study:

The market valuation in 2022 was USD 9 million.
Based on product type, portable/handheld ultrasound scanners are expected to dominate at a market share of 86.5% in 2023.
Based on imaging technology, digital imaging technology will register at a market share of 93.7% in 2023.
The veterinary ultrasound scanner market size expanded at 4.6% CAGR between 2018 and 2022.
India is estimated to expand at a CAGR of 5.5% by 2033.
Germany experiences a significant rise, with a CAGR of 2.2% by 2033.

“Technological advancements have largely influenced the veterinary care market and also affected the veterinary ultrasound scanner demand is thus considered one of the major drivers of the veterinary ultrasound scanner market,” comments a Future Market Insights analyst.

Discover Market Trends: Access the Full Veterinary Ultrasound Scanner Market Report

Drivers of Growth:

Increased awareness and importance of animal healthcare: This includes rising pet ownership, growing concern about zoonotic diseases (diseases transmissible between animals and humans).
Technological advancements: Advancements in ultrasound technology lead to more accurate and efficient diagnoses.
Rising expenditure on animal health: Pet owners are spending more on their pets’ well-being, including diagnostics.
Pet insurance adoption: Increased pet insurance allows for more comprehensive veterinary care, including ultrasound scans.
Government initiatives: Supportive government programs promoting animal health can contribute to market growth.

Competitive Landscape:

The veterinary ultrasound scanner industry boasts a substantial array of market participants. Research and development play a pivotal role among these players, primarily focusing on introducing eco-friendly product lines as a core aspect of their manufacturing endeavors. Furthermore, they employ various expansion strategies, including collaborations, mergers and acquisitions, and diligent exploration of regulatory approvals to bolster their market presence.

Some of the key developments are-

Butterfly Network Inc., a trailblazing digital health firm recognized for its innovative product approach, recently unveiled its latest veterinary ultrasound device. The iQ+ Vet ultrasound introduces a cutting-edge guidance tool and hardware enhancements, promising sharper imaging for improved diagnostics.
Lacuna Diagnostics Inc., a pioneering telemedicine and point-of-care diagnostics company, entered into a comprehensive acquisition agreement with Heska Corporation.

Key Companies Profiled:

Siemens AG
Mindray Medical International Limited
Hitachi Ltd.
Fujifilm Holdings Corporation
General Electric Company
Canon Inc.
Samsung Electronics Co. Ltd.
Esaote SpA
DRAMI?SKI S. A.
IMV Technologies SA

Key Segments of Veterinary Ultrasound Scanners Industry Survey:

By Product Type:

Portable/Hand Held Ultrasound Scanners
Cart Based Ultrasound Scanners

By Imaging Technology:

Digital Imaging Technology
Analog Imaging Technology
Contrast Imaging Technology

By End User:

Veterinary Hospitals
Veterinary Clinics
Animal Breeding and Farms

By Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia and Pacific
East Asia
The Middle East & Africa

About Future Market Insights (FMI)

Contact Us:

Global Patient-Controlled Analgesia Pumps Market Set for Remarkable Growth, Projected to Reach USD 729.1 Million by 2033

The global Patient-Controlled Analgesia pumps market is poised for substantial expansion over the next decade, according to recent market analysis. Driven by the increasing demand for advanced pain management solutions, the market is expected to grow at a robust Compound Annual Growth Rate (CAGR) of 5% throughout the forecast period.

As of 2023, the PCA pumps market has already achieved a notable valuation of USD 447 million. With a promising growth trajectory, analysts forecast that this figure will surge to an impressive USD 729.1 million by 2033. This anticipated growth underscores the significant opportunities for industry stakeholders and highlights the sector’s potential for long-term success.

Patient-controlled analgesia pumps empower patients with enhanced control over pain management, contributing to improved healthcare outcomes and patient satisfaction. This technology enables patients to self-administer medication within prescribed limits, offering personalized pain relief tailored to individual needs.

Key factors propelling market growth include advancements in healthcare infrastructure, increasing surgical procedures, and rising prevalence of chronic pain conditions globally. These trends are driving healthcare providers to adopt more efficient and patient-centric pain management solutions, thereby boosting demand for patient-controlled analgesia pumps.

“The projected growth of the patient-controlled analgesia pumps market reflects evolving healthcare preferences towards personalized and effective pain management solutions,” said FMI. “This expansion presents substantial opportunities for manufacturers and healthcare providers to innovate and cater to the growing demand for patient-centered care.”

The forecasted growth of the patient-controlled analgesia pumps market not only signifies a shift towards more sophisticated pain management techniques but also underscores the industry’s commitment to improving patient outcomes and quality of life.

Global Patient-Controlled Analgesia Pumps Market: Dynamics

The growth of the global patient-controlled analgesia pumps market is influenced by aspects such as various advantages of PCA system over conventional continuous infusion systems, increasing standardization for reducing costs in hospitals, development of quality indicators for patient-controlled analgesia pumps, modernization with a view to reduce errors, increasing adoption of PCA owing to increasing prevalence of cancer, pain and diabetes, rising forward integration and increasing demand for PCA in rental and homecare services.

These factors have contributed to the growth of the global market. On the contrary, lack of skilled manpower and lack of standard usage guidelines and vast product recalls are hampering the growth of the global patient-controlled analgesia pumps market. Various trends have been observed, to name a few, rapid med-tech progress, shifting production base to emerging economies, user-friendly advanced equipment and fragmented market. Opportunities such as increasing production base for smart pumps with bigger drug libraries and expanding production base for PCA, ambulatory and other pumps have been

Key Takeaways:

The electronic PCA pumps segment is expected to account for the largest market share during the forecast period, owing to the increasing adoption of advanced technologies in the healthcare sector.
The hospital segment is expected to dominate the market in terms of revenue, owing to the high demand for PCA pumps in hospitals for the treatment of post-operative pain and chronic pain.
North America is expected to remain the largest market for PCA pumps during the forecast period, owing to the high prevalence of chronic diseases and the high adoption of advanced technologies in the healthcare sector.
Asia Pacific is expected to be the fastest-growing market for PCA pumps during the forecast period, owing to the increasing prevalence of chronic diseases and the rising demand for ambulatory care.

Get Old Source Most Recent Reports Are Available Now…

Other key trends that are expected to drive the growth of the PCA pumps market include:

The increasing demand for minimally invasive surgeries, which require the use of PCA pumps for pain management.
The growing awareness of the benefits of PCA pumps, such as improved pain control, reduced risk of side effects, and faster recovery.
The development of new and innovative PCA pumps, such as wearable and disposable PCA pumps.

Key Companies Profiled:

Smiths Group plc.
Fresenius Kabi Group,
Hospira (Pfizer Inc.),
Micrel Medical Devices,
Ace Medical Co. Ltd.
Terumo Corporation,
B.Braun Melsungen AG
Baxter International
Becton Dickinson and Company.
BD
ICU Medical

Key Market Segments Covered in Patient-Controlled Analgesia Pumps Industry Research:

By Product:

PCA Pumps
Pump Accessories

By Application:

Chemo Therapy/Oncology
Pediatrics/Neonatology
Gastroenterology
Hematology

By End-User:

Hospitals
Ambulatory Surgical Centers
Home care settings

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)

About Future Market Insights (FMI)

Contact Us:

Global Tinea Pedis Treatment Market Value Set to Total USD 2,484 Million by 2034 at a 5.2% CAGR

The global tinea pedis treatment market is estimated to be valued at USD 1,496.3 million in 2024. Global demand will likely increase at 5.2% CAGR, with total industry size reaching USD 2,484 million by 2034.

Antifungals remain the most preferred drugs to treat tinea pedis. The target segment accounted for a revenue share of 71.8% in 2023. Antifungal medications specifically target the fungi responsible for causing tinea pedis infections, such as dermatophytes like Trichophyton rubrum and Trichophyton mentagrophytes.

By inhibiting fungal growth or killing the fungi outright, antifungals effectively treat the underlying cause of the infection, providing symptomatic relief and promoting healing. These medications are gaining popularity due to their targeted action.

Several factors are expected to stimulate the growth of the tinea pedis market during the assessment period. These include the escalating prevalence of fungal infections like tinea pedis, growing health awareness, and the development of novel antifungal medications.

Tinea pedis is one of the most common fungal infections globally, affecting individuals of all ages and demographics. The prevalence of tinea pedis varies across regions, with higher rates often observed in warm and humid climates where the environment is conducive to fungal growth.

Countries with high population densities, inadequate sanitation facilities, and limited access to healthcare are experiencing a higher burden of tinea pedis infections. The widespread prevalence of tinea pedis, influenced by factors such as gender, age, and lifestyle habits, serves as a key driver for the tinea pedis treatment market.

As the incidence of tinea pedis continues to grow globally, so will demand for tinea pedis treatment. Patients with tinea pedis often opt for antifungals and other medications to relieve symptoms and cure this fungal infection.

Advances in medical research and technology are allowing companies to develop more effective and convenient treatment solutions. This will further boost industry growth during the assessment period.

Key Takeaways from the Market Study:

The global tinea pedis treatment industry is set to advance at 2% CAGR through 2034.
By disease indication, the interdigital tinea pedis is forecast to account for a share value of 4% in 2024.
By route of administration, the topical segment will likely hold a value share of 4% in 2024.
By distribution channel, the hospital pharmacies segment is anticipated to hold a market share of 4% in 2024.
By drug class, the antifungal category dominates the market, accounting for 8% of the market share value in 2023.
The United States is poised to exhibit a CAGR of 2% through 2034.
Demand in China is predicted to increase at 3% CAGR between 2024 and 2034.

“Medical research has fuelled the creation of potent topical antifungal creams and ointments specifically tailored to combat tinea pedis. Development of these new enhanced formulations will bode well for the industry during the assessment period,” says a lead analyst of Future Market Insights (FMI).

Find the Latest Updates on Get Old Source Reports…

Who is Winning?

Glenmark Pharmaceuticals Inc., USA, McKesson (NorthStar Rx LLC), Camber Pharmaceuticals, Inc., Sebela Pharmaceuticals, Inc., Blueberry Therapeutics Ltd., Exeltis USA, Inc., Viatris (Mylan N.V.), Bayer AG, GlaxoSmithKline Plc (GSK), and Novartis AG are few of the leading players listed in the report.

Top companies are constantly striving to develop new antifungal medications with enhanced antifungal activity, reduced side effects, and improved skin compatibility. They are also implementing strategies like acquisitions, distribution agreements, and partnerships to stay ahead of the competition.

Industry Updates:

In January 2024, Sun Pharmaceutical Industries Limited and Taro Pharmaceutical Industries Ltd. entered into a definitive merger agreement.
In September 2023, Aurobindo Pharma announced that it was entering the Indonesian market by acquiring 15 formulation brands from Pfizer Inc. and Viatris Inc.

Key Segments of Market Report:

By Disease Indication:

As per disease indication, the industry has been categorized into interdigital tinea pedis, plantar tinea pedis, and vesicular tinea pedis.

By Route of Administration:

Based on route of administration, the report is segmented into topical and oral. The topical segment is further divided into gel, cream, spray, lotion, and powder.

By Distribution Channel:

Different distribution channels include hospital pharmacies, retail pharmacies, drug stores, and online pharmacies.

By Drug Class:

In terms of drug class, the industry is categorized into antifungals and combinations.

By Region:

Industry analysis has been carried out in key countries of North America, Latin America, Europe, South Asia, East Asia, Oceania, and the Middle East and Africa.

About Future Market Insights (FMI)

Contact Us: